“the-column-group” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic 03/25/20 New York
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
After Amgen’s Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs 07/09/19 San Francisco
With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field 06/19/19 San Francisco
Merck Preempts Peloton Therapeutics IPO With $1B Acquisition Deal 05/21/19 New York
Peloton Therapeutics Plans IPO for Kidney Cancer Drug Clinical Trials 04/29/19 Texas
NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing 04/03/19 San Francisco
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy 02/20/19 Texas
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer 01/04/19 Boston
With $40M Banked, Escient Building for Fast Move to Human Trials 06/01/18 San Diego
Accent Therapeutics Debuts With $40M To Target RNA Modification 05/18/18 Boston
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
Will Fast-Growing Kallyope Stay in New York After New $66M Round? 02/22/18 New York
With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up 11/08/17 Boston
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs 07/25/17 San Diego
Texas Roundup: SXSW Odds & Ends, Dosh, Mythic, Peloton, & More 03/22/17 Texas
Regenerative Med Firm Surrozen Unveils $33M to Tackle Tissue Repair 02/15/17 San Francisco
REVOLUTION Medicines Garners $25,000,000 Series A Funding 12/22/16 San Francisco
Tenaya Spins Out of Gladstone With $50M to Fight Heart Disease 12/07/16 San Francisco
Roundup: DIUx, Scraffic, Peloton, Pitchocracy, & Alamo City Angels 09/19/16 Texas
Dallas-Based Peloton Raises $52.4M for Kidney Cancer Drug Candidate 09/15/16 Texas
FLX Bio Secures $50,000,000 Series B Financing 04/30/16 San Francisco
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
Stealthy MIT Spinout Ribon, Led by a Sanofi Vet, Takes Aim at Cancer 03/03/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
Page 1 of 4 next page »